IPO Outlook: CoLucid Offers Hope For Migraine Sufferers By: Benzinga via Benzinga April 29, 2015 at 08:20 AM EDT Headache combatant CoLucid Pharmaceuticals (NASDAQ: CLCD) is three days from going public Friday, May 1. The biopharmaceutical ... Read More >> Related Stocks: Black Stone Minerals LP Blueprint Medicines Corp Eli Lilly Enviva Partners LP Renaissance International IPO ETF Viking Thera